Retrospective chart review of FreeStyle Libre in adults with type 2 diabetes
Not Applicable
- Conditions
- Diabetes mellitus (diabetes)Nutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN15121154
- Lead Sponsor
- Abbott (United Kingdom) Diabetes Care Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
1. Age 18 years or over
2. Has type 2 diabetes using basal-bolus insulin regimen for at least 1 year
3. Has used FreeStyle Libre/Libre 2 regularly for at least 3 months
4. HbA1c recorded in medical notes between 8.0% and 12.0% (64 to 108 mmol/mol) in the 3 months prior to starting FreeStyle Libre/Libre 2
5. HbA1c recorded in medical notes 3 to 6 months after starting FreeStyle Libre/Libre 2
Exclusion Criteria
1. Female participant who was pregnant during the data collection period
2. Received dialysis treatment during the data collection period
3. Participated in another device or drug study that could have affected glucose measurements or management during the data collection period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin A1c (HbA1c) level measured using the FreeStyle Libre sensor and recorded in medical charts at baseline and 3 to 6 months after initiation
- Secondary Outcome Measures
Name Time Method There are no secondary outcome measures